Markus Frederic Renschler
Markus Frederic Renschler publishes mostly in Pulmonary and Respiratory Medicine, Oncology and Molecular Biology, on topics such as Brain Metastases and Treatment, Lung Cancer Research Studies and Lung Cancer Treatments and Mutations.
- World rank
- #536,442 of 7,710,434 ranked researchers
- Rank in United States
- #185,801 of 1,627,098
- Works
- 103
- Citations
- 12k
- Citations per work
- 118.6
What does Markus Frederic Renschler research?
Markus Frederic Renschler's work is mostly in Medicine (68%), Biochemistry, Genetics and Molecular Biology (14%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences7067.8%
- Medicine7067.8%
- Everything else1918.7%
- Life Sciences1413.5%
- 1Pulmonary and Respiratory Medicine30% of their works
- 2Oncology27% of their works
- 3Molecular Biology10% of their works
- 4Radiology, Nuclear Medicine and Imaging7% of their works
- 5Genetics4% of their works
- 6Cancer Research4% of their works
Research topics
Which keywords describe Markus Frederic Renschler's research?
The keywords of their largest research topics: Immunotherapy, Clinical Trials, Targeted Therapy, Chemotherapy, Brain Metastases, Radiosurgery, Genomic Profiles and Small-Cell Lung Cancer.
- MRI Contrast Agents
- Surgical Complications
- Temozolomide
- Topoisomerases
- Taxanes
- EGFR Mutations
- Small-Cell Lung Cancer
- Radiosurgery
- Chemotherapy
- Clinical Trials
- Immunotherapy
- Targeted Therapy
- Brain Metastases
- Genomic Profiles
- ALK Inhibitors
- Chemotherapy-Induced Peripheral Neuropathy
- DNA
- Glioblastoma
- Pancreatic Cancer
- Lanthanide Luminescence
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 20 words, with their numbers
- Immunotherapy1024 topics
- Clinical Trials662 topics
- Targeted Therapy662 topics
- Chemotherapy633 topics
- Brain Metastases411 topic
- Radiosurgery411 topic
- Genomic Profiles371 topic
- Small-Cell Lung Cancer371 topic
- ALK Inhibitors291 topic
- EGFR Mutations291 topic
- Chemotherapy-Induced Peripheral Neuropathy181 topic
- Taxanes181 topic
- DNA151 topic
- Topoisomerases151 topic
- Glioblastoma131 topic
- Temozolomide131 topic
- Pancreatic Cancer111 topic
- Surgical Complications111 topic
- Lanthanide Luminescence101 topic
- MRI Contrast Agents101 topic
Where does Markus Frederic Renschler work?
Markus Frederic Renschler's main affiliation in the publication record is Pharmacyclics (United States), United States.
How many publications and citations does Markus Frederic Renschler have?
OpenAlex counts 103 works and 12,219 citations for Markus Frederic Renschler, an h-index of 30, ranking #536,442 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Markus Frederic Renschler. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.